Scott H. Shaffer
<p><span>Scott Shaffer, MD is assistant professor of psychiatry and behavioral sciences and pediatrics at the Albert Einstein College of Medicine. He is director of the Child and Adolescent Psychiatry Consult/Liaison Service at the Children's Hospital at Montefiore, and is the deputy training director of the child and adolescent psychiatry fellowship at the Albert Einstein College of Medicine. He completed his residency in psychiatry at the Alpert Medical School of Brown University, and his fellowship in child and adolescent psychiatry at the New York University School of Medicine. </span></p>
<p>Dr. Shaffer is a board member of the New York Council on Child and Adolescent Psychiatry. He is also chair of the Advisory Council for the Gold Humanism Honor Society and is a member of the Arnold P Gold Foundation Board of Trustees. </p>
Dr. Shaffer’s clinical focus is around the evaluation and treatment of somatic symptom disorders, autism spectrum disorder, and medical education. His research focus is on somatic symptom disorders and medical education.
<p>Samuels A, Tuvia T, Patterson D, Briklin O, <strong>Shaffer S</strong>, Walker A. <a href="https://www.ncbi.nlm.nih.gov/pubmed/31267759/">Characteristics of Conversion Disorder in an Urban Academic Children's Medical Center. </a>Clin Pediatr (Phila). 2019 Jul 3; [Epub ahead of print] PubMed PMID: 31267759.</p>
<p> </p>
<p>Denysenko L, Sica N, Penders T, Philbrick K, Walker A, <strong>Shaffer S, </strong>Zimbrean P, Freudenreich O, Rex N, Carroll B, Francis A. Catatonia in the medically ill: Etiology, Diagnosis, and treatment. The Academy of Consultation-Liaison Psychiatry Evidence-based Medicine Subcommittee Monograph. Annals of Clinical Psychiatry 2018:30(2), 140-155.</p>
<p> </p>
<p><strong>Shaffer S</strong>., Fuentes J. On or off the “Spectrum”? The complexity of screening and diagnosing autism spectrum disorder (ASD). JAACAP Connect. Volume 1 Issue 2, Fall 2014.</p>
<p><strong> </strong></p>
<p>Philip NS, <strong>Shaffer S</strong>, Banik D, Johnson B: Supportive Psychotherapy- a Crash Course for Medical Students. Academic Psychiatry 2010: 34:1, 57-60.</p>
<p>Scott Shaffer, MD, is Director of Child and Adolescent Psychiatry Consult-Liaison Service and Deputy Director of Training, Child and Adolescent Psychiatry. He is also an Assistant Professor at our Albert Einstein College of Medicine.
</p><p>After receiving his Bachelor of Arts degree in Biological Sciences from Rutgers University in 2003, Dr. Shaffer continued his education at Rutgers-Robert Wood Johnson Medical School where he earned his Doctor of Medicine degree in 2006. He earned his first residency in General Psychiatry from Warren Alpert Medical School of Brown University in 2010 and his second residency in Child and Adolescent Psychiatry from the New York University School of Medicine in 2012.
</p><p>Dr. Shaffer’s clinical focus is around the evaluation and treatment of somatic symptom disorders, autism spectrum disorder, and medical education. His research focus is on somatic symptom disorders and medical education.
</p><p>Dr. Shaffer is board certified and involved in a number of committees. He is Chair of the Nominating Committee and on the Advisory Council for the Gold Humanism Honor Society, a program of the Arnold P. Gold Foundation. Along with being a Board Member for the New York Council of the American Academy of Child and Adolescent Psychiatry he is also Co-Chair of their Medical Student Subcommittee. At the Albert Einstein College of Medicine, Dr. Shaffer serves as a co-chair for the Committee on Admissions, and is a member of the Clinical Skills Assessment Subcommittee, and the Child Psychiatry Executive Training Committee.
</p><p>He is an active member of the American Academy of Child and Adolescent Psychiatry, New York Council of the American Academy of Child and Adolescent Psychiatry, and Gold Humanism Honor Society.
</p>
Charles C. Esenwa
<p>Charles Esenwa is an Assistant Professor of Neurology at Albert Einstein College of Medicine and clinical stroke neurologist at Montefiore Medical Center. Dr. Esenwa attended medical school at SUNY Downstate College of Medicine, and completed a residency in Neurology at the Neurological Institute of New York, where he also served as chief resident and a fellow in vascular neurology. While at Columbia, he completed formal training in neuroepidemiology under an NIH T32 grant.<br />He is dedicated to humanistic patient care and is the recipient of the Arnold P. Gold Humanism in Medicine Award, and the Neurological Institute’s Daniel Sciarra patient care and humanism award. He has published on acute stroke management, stroke risk factors, secondary stroke prevention and stroke disparities, and is interested in advancing health care delivery to populations on the local, national and international levels.</p>
Dr. Esenwa specializes in acute stroke care and stroke prevention in high-risk communities. He is the medical director of the Montefiore Comprehensive Center for Stroke Care.
<p class="MsoListParagraph" style="mso-add-space: auto; line-height: normal; mso-outline-level: 1; background: white; margin: 12.0pt 0in 6.0pt 0in;"><span style="font-family: 'Verdana',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; color: black; mso-color-alt: windowtext; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Journal Publications</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa C</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">, Cheng NT, Lipsitz E, Hsu K, Zampolin R, Gersten A, Antoniello D, Soetanto A, Kirchoff K, Liberman A, Mabie P, Nisar T, Rahimian D, Brook A, Lee SK, Haranhalli N, Altschul D, Labovitz D. <em>COVID-19-Associated Carotid Atherothrombosis and Stroke.</em> AJNR Am J Neuroradiol. 2020 Aug 20. doi: 10.3174/ajnr.A6752.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa C,</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;"> Parides MK, Labovitz DL. <em>The effect of COVID-19 on stroke hospitalizations in New York City</em>. J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105114. doi: 10.1016/j.jstrokecerebrovasdis.2020.105114. Epub 2020 Jul 13.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Altschul DJ, <strong>Esenwa C</strong>, Haranhalli N, Unda SR, de La Garza Ramos R, Dardick J, Fernandez-Torres J, Toma A, Labovitz D, Cheng N, Lee SK, Brook A, Zampolin R. <em>Predictors of mortality for patients with COVID-19 and large vessel occlusion</em>. Interv Neuroradiol. 2020 Oct;26(5):623-628. doi: 10.1177/1591019920954603. Epub 2020 Aug 30. PMID: 32862753.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Liberman AL, Wang C, Friedman BW, Prabhakaran S, <strong>Esenwa CC</strong>, Rostanski SK, Cheng NT, Erdfarb A, Labovitz DL, Lipton RB. <em>Head Computed tomography during emergency department treat-and-release visit for headache is associated with increased risk of subsequent cerebrovascular disease hospitalization</em>. Diagnosis (Berl). 2020 Oct 5:/j/dx.ahead-of-print/dx-2020-0082/dx-2020-0082.xml. </span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">McHugh DC<strong>, Esenwa C</strong>. A Novel COL4A2 <em>Mutation Associated with Recurrent Strokes</em>. J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105156. doi:</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Altschul DJ, Haranhalli N, <strong>Esenwa C</strong>, Unda SR, de La Garza Ramos R, Dardick J, Fernandez-Torres J, Toma A, Labovitz D, Cheng N, Lee SK, Brook A, Zampolin R. <em>The Impact of COVID-19 on Emergent Large-Vessel Occlusion: Delayed Presentation Confirmed by ASPECTS.</em> AJNR Am J Neuroradiol. 2020 Sep 3. doi: 10.3174/ajnr.A6800.</span></p>
<p class="desc" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Liberman AL, Navi BB, <strong>Esenwa</strong> CC, Zhang C, Song J, Cheng NT, Labovitz DL, Kamel H, Merkler AE. <em>Misdiagnosis of Cervicocephalic Artery Dissection in the Emergency Department.</em></span></p>
<p class="details" style="margin: 0in 0in 0in .5in;"><span class="jrnl"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Stroke</span></span><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">. 2020 Apr 16:STROKEAHA120029390. doi: 10.1161/STROKEAHA.</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">, C. et al<em>. Racial Differences in Mechanical Thrombectomy Utilization for Ischemic Stroke in the United States</em>. Ethn Dis 30, 91-96 (2020).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Liberman, A. L., Bakradze, E., McHugh, D. C., </span><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa, </span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">C. C. & Lipton, R. B. <em>Assessing diagnostic error in cerebral venous thrombosis via detailed chart review.</em> Diagnosis (Berl) 6 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa,</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;"> C., Labovitz, D. & Caplan, L. R. "Basilar Web" Causing Basilar Branch Infarction. J Stroke Cerebrovasc Dis 28, 104366 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Dardick, </span><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa, C</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">., et al. <em>Acute Lateral Medullary Infarct due to Giant Cell Arteritis: A Case Study</em>. Stroke 50, e290-e293 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Bakradze E, Kirchoff KF, Antoniello D, Springer MV, Mabie PC, </span><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black;">Esenwa CC,</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;"> Labovitz DL, Liberman AL.<em>Varicella Zoster Virus Vasculitis and Adult Cerebrovascular Disease</em>. Neurohospitalist 9, 203-208 (2019).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">Esenwa, C</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">., Tshiswaka, DL., Gebregziabher, M., Ovbiagele, B. <em style="mso-bidi-font-style: normal;"><span style="mso-bidi-font-weight: bold;">Historical Slavery and Modern-Day Stroke Mortality in the United States Stroke Belt</span></em><span style="mso-bidi-font-weight: bold;">.<em> Stroke</em>. 2018 (in press)</span></span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Boehme, A., <strong>Esenwa</strong>, C., Elkind, M.S. </span><em style="mso-bidi-font-style: normal;"><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;">Stroke Risk Factors, Genetics, and Prevention.</span></em><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-bidi-font-weight: bold;"> Circulation Research. 120, 3 (2017)</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C.C. & Elkind, M.S. <em style="mso-bidi-font-style: normal;">Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke</em>. Nat Rev Neurol 12, 594-604 (2016).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C. & Gutierrez, J. <em style="mso-bidi-font-style: normal;">Secondary stroke prevention: challenges and solutions</em>. Vasc Health Risk Manag 11, 437-50 (2015).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C.C. & Elkind, M.S<em style="mso-bidi-font-style: normal;">. A questionable cause of intracerebral hemorrhage.</em> JAMA Neurol 70, 653-4 (2013).</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">Kummer B, Kerner B,<strong style="mso-bidi-font-weight: normal;"> Esenwa C. </strong><em style="mso-bidi-font-style: normal;">Voltage Gated Potassium Channel Antibody Encephalitis Associated with Hyperglycemia</em>. J Clin Case Rep. 2014 Dec. 4:464</span></p>
<p class="details" style="text-indent: -.25in; mso-list: l1 level1 lfo2; margin: 0in 0in 0in .5in;"><!-- [if !supportLists]--><span style="font-size: 11.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa</span></strong><span style="font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, C.C. & Leaf, D.E. <em style="mso-bidi-font-style: normal;">Colpocephaly in adults.</em> BMJ Case Rep 2013 (2013).</span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial;">Book Publications </span></p>
<ul style="margin-top: 0in;" type="disc">
<li class="MsoNormal" style="mso-list: l0 level1 lfo1; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa C</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Czeisler B, Mayer S. 2015<em style="mso-bidi-font-style: normal;">. Chapter 35</em>, <em style="mso-bidi-font-style: normal;">Acute Ischemic Stroke</em>.</span><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;"> In E. Louis, S. Mayer and L. Rowland</span><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Merritt’s Neurology Thirteenth Ed. Philadelphia, PA: Walters Kluwer.</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo1; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt;">Esenwa C</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Elkind M. 2015. <em style="mso-bidi-font-style: normal;">Chapter 44, </em></span><em style="mso-bidi-font-style: normal;"><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;">Primary and Secondary Stroke Prevention</span></em><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;">. In E. Louis, S. Mayer and L. Rowland</span><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Merritt’s Neurology Thirteenth Ed. Philadelphia, PA: Walters Kluwer.</span></li>
<li class="MsoNormal" style="mso-list: l0 level1 lfo1; text-autospace: ideograph-numeric ideograph-other;"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Rinaldi A, <strong>Esenwa C.</strong> 2015. <em style="mso-bidi-font-style: normal;">Chapter 121, Gastric and Genitourinary Function and the Brain</em></span><span lang="EN" style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-ansi-language: EN;">.<span style="mso-spacerun: yes;"> </span>In E. Louis, S. Mayer and L. Rowland</span><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">, Merritt’s Neurology Thirteenth Ed. Philadelphia, PA: Walters Kluwer.</span></li>
</ul>
<p class="MsoNormal" style="margin-bottom: 6.0pt; mso-outline-level: 1; background: white;"> </p>
<p class="MsoNormal" style="margin-bottom: 6.0pt; mso-outline-level: 1; background: white;"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif; mso-bidi-font-family: Arial; color: black; mso-font-kerning: 18.0pt; mso-bidi-font-weight: bold;">Abstracts:</span></p>
<ul type="disc">
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Esenwa et al</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">. <em>Identifying acute ischemic stroke by analyzing ICD-10 claims data using machine learning models. International Stroke Conference 2017 meeting.</em></span></li>
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Esenwa et al</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">. <em>Identifying stroke subtypes with high accuracy using machine learning and ICD-9 claims data</em>. International Stroke Conference 2017 meeting.</span></li>
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Esenwa et al</span></strong><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">. <em>T1 Rho Magnetic Resonance (MR) imaging can quantify acute cerebrovascular infarct in humans and is stable in the subacute period. </em>International Stroke Conference 2017 meeting.</span></li>
<li class="MsoNormal" style="color: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 13.65pt; mso-list: l2 level1 lfo3; tab-stops: list .5in; text-autospace: ideograph-numeric ideograph-other;"><span style="mso-bidi-font-size: 11.0pt; font-family: 'Verdana',sans-serif;">Soun J & <strong>Esenwa </strong>C. Quantitative T1 Rho MR imaging of Acute Ischemic Infarct. ASNR meeting April, 2016 Poster</span></li>
</ul>
<p>Charles C. Esenwa, MD, MS, is a Director at Montefiore’s Center for Comprehensive Stroke and Assistant Professor at our Albert Einstein College of Medicine. He specializes in vascular neurology, with a particular interest in acute stroke management and stroke prevention strategies in high-risk individuals.</p><p>After receiving his Bachelor of Science in microbiology from Penn State University in 2006, Dr. Esenwa attended SUNY Downstate Medical Center, earning his medical degree in 2010. He pursued his postdoctoral training at NewYork-Presbyterian Hospital, completing a medical internship in 2011 and a residency in the department of neurology in 2014. He was invited to complete an additional year, serving as chief resident for the department of neurology. From 2015 to 2017, he continued at the institution as a vascular neurology clinical and neuroepidemiology postdoctoral fellow. In 2017, he earned his Master of Science in neuroepidemiology from Columbia University Mailman School of Public Health.</p><p>Dr. Esenwa’s research focus is on acute stroke management, stroke risk factors and stroke prevention. His research has been published in several reviewed journals, books and abstracts.</p><p>Dr. Esenwa is the recipient of the 2010 Leonard Tow Humanism in Medicine Award from the Arnold P. Gold Foundation and the 2014 Columbia University Department of Neurology Daniel Sciarra Award for patient care and humanism. He was selected to participate in the American Academy of Neurology’s Emerging Leaders Program in 2018-2019. Dr. Esenwa is an active board member of the New York State Neurological Society, and he is a member of the American Heart Association and the American Academy of Neurology.</p>
Elizabeth L. Chapman
Ammar Y. Ahmad
Dr. Ahmad's clinical focus is psychosomatic medicine, with particular interest in heart and lung transplant psychiatry.
Dr. Ahmad’s research focuses on psychosomatic medicine and medical ethics, particularly in the area of organ transplantation selection.
<p>Ammar Yasser Ahmad, MD, is Attending Psychiatrist at Montefiore. His clinical focus is psychosomatic medicine, with particular interest in heart and lung transplant psychiatry.</p><p>In 2007, Dr. Ahmad received his Bachelor of Science in history and biology at the University of Pittsburgh. He then attended St. George’s University, where he received his Doctor of Medicine in 2014. He began his postgraduate training in 2015 with a four-year residency in psychiatry at the Bergen New Bridge Medical Center, becoming Chief Resident in his final year. In 2019, he began a yearlong fellowship in consultation-liaison psychiatry at Montefiore. In 2020, Dr. Ahmad completed the certificate program in bioethics and medical humanities at our Albert Einstein College of Medicine.</p><p>Dr. Ahmad’s research focuses on psychosomatic medicine and medical ethics, particularly in the area of organ transplantation selection. His work has been published in a number of abstracts.</p><p>In 2020, Dr. Ahmad received the Davidoff Teaching Award. He is board certified by the American Board of Psychiatry and Neurology and a member of the American Psychiatric Association. </p>